Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Urologic Neoplasms × galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1

Conditions

Urologic Neoplasms 1 Neoplasms 1 Colorectal Neoplasms 1

Interventions

zidovudine 5'-monophosphate-mannose-albumin conjugate 1 tislelizumab 1 pembrolizumab 1 galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 1 atezolizumab 1 Water 1 Therapeutics 1 Surgical Procedures, Operative 1 Ringer's acetate 1 Preoperative Exercise 1 Nutritional Support 1 Immunoglobulins, Intravenous 1 Exercise 1 Ethanol 1 Dosage Forms 1 Biological Therapy 1 Albumins 1 Adiposity 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05726136 2024-03-18

FC-VE

University Hospital, Linkoeping

Phase 4 Unknown

GastrointestinalGenitourinary

Neoplasms, Urologic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡